Furthermore, administration of an RSK1 inhibitor or caspase-3 activator boosts the efficacy of gemcitabine in murine models of ICC.<h4>Conclusion</h4>NRXN3 plays a crucial role in maintaining chemotherapy-induced pyroptosis in ICC. The gene discussed is NRXN3; the disease is intrahepatic cholangiocarcinoma.